tetano
Editor, Senior Moderator
Cells
. 2022 Apr 21;11(9):1408.
doi: 10.3390/cells11091408.
Human Wharton's Jelly Mesenchymal Stem Cells Secretome Inhibits Human SARS-CoV-2 and Avian Infectious Bronchitis Coronaviruses
Mohamed A A Hussein[SUP] 1 [/SUP], Hosni A M Hussein[SUP] 1 [/SUP], Ali A Thabet[SUP] 2 [/SUP], Karim M Selim[SUP] 3 [/SUP], Mervat A Dawood[SUP] 4 [/SUP], Ahmed M El-Adly[SUP] 1 [/SUP], Ahmed A Wardany[SUP] 1 [/SUP], Ali Sobhy[SUP] 5 [/SUP], Sameh Magdeldin[SUP] 6 7 [/SUP], Aya Osama[SUP] 6 [/SUP], Ali M Anwar[SUP] 6 [/SUP], Mohammed Abdel-Wahab[SUP] 2 [/SUP], Hussam Askar[SUP] 2 [/SUP], Elsayed K Bakhiet[SUP] 1 [/SUP], Serageldeen Sultan[SUP] 8 [/SUP], Amgad A Ezzat[SUP] 9 [/SUP], Usama Abdel Raouf[SUP] 10 [/SUP], Magdy M Afifi[SUP] 1 [/SUP]
Affiliations
Abstract
Human SARS-CoV-2 and avian infectious bronchitis virus (IBV) are highly contagious and deadly coronaviruses, causing devastating respiratory diseases in humans and chickens. The lack of effective therapeutics exacerbates the impact of outbreaks associated with SARS-CoV-2 and IBV infections. Thus, novel drugs or therapeutic agents are highly in demand for controlling viral transmission and disease progression. Mesenchymal stem cells (MSC) secreted factors (secretome) are safe and efficient alternatives to stem cells in MSC-based therapies. This study aimed to investigate the antiviral potentials of human Wharton's jelly MSC secretome (hWJ-MSC-S) against SARS-CoV-2 and IBV infections in vitro and in ovo. The half-maximal inhibitory concentrations (IC[SUB]50[/SUB]), cytotoxic concentration (CC[SUB]50[/SUB]), and selective index (SI) values of hWJ-MSC-S were determined using Vero-E6 cells. The virucidal, anti-adsorption, and anti-replication antiviral mechanisms of hWJ-MSC-S were evaluated. The hWJ-MSC-S significantly inhibited infection of SARS-CoV-2 and IBV, without affecting the viability of cells and embryos. Interestingly, hWJ-MSC-S reduced viral infection by >90%, in vitro. The IC[SUB]50[/SUB] and SI of hWJ-MSC secretome against SARS-CoV-2 were 166.6 and 235.29 µg/mL, respectively, while for IBV, IC[SUB]50[/SUB] and SI were 439.9 and 89.11 µg/mL, respectively. The virucidal and anti-replication antiviral effects of hWJ-MSC-S were very prominent compared to the anti-adsorption effect. In the in ovo model, hWJ-MSC-S reduced IBV titer by >99%. Liquid chromatography-tandem mass spectrometry (LC/MS-MS) analysis of hWJ-MSC-S revealed a significant enrichment of immunomodulatory and antiviral proteins. Collectively, our results not only uncovered the antiviral potency of hWJ-MSC-S against SARS-CoV-2 and IBV, but also described the mechanism by which hWJ-MSC-S inhibits viral infection. These findings indicate that hWJ-MSC-S could be utilized in future pre-clinical and clinical studies to develop effective therapeutic approaches against human COVID-19 and avian IB respiratory diseases.
Keywords: Wharton’s jelly stem cells; coronaviruses; infectious bronchitis virus (IBV); secretome; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
. 2022 Apr 21;11(9):1408.
doi: 10.3390/cells11091408.
Human Wharton's Jelly Mesenchymal Stem Cells Secretome Inhibits Human SARS-CoV-2 and Avian Infectious Bronchitis Coronaviruses
Mohamed A A Hussein[SUP] 1 [/SUP], Hosni A M Hussein[SUP] 1 [/SUP], Ali A Thabet[SUP] 2 [/SUP], Karim M Selim[SUP] 3 [/SUP], Mervat A Dawood[SUP] 4 [/SUP], Ahmed M El-Adly[SUP] 1 [/SUP], Ahmed A Wardany[SUP] 1 [/SUP], Ali Sobhy[SUP] 5 [/SUP], Sameh Magdeldin[SUP] 6 7 [/SUP], Aya Osama[SUP] 6 [/SUP], Ali M Anwar[SUP] 6 [/SUP], Mohammed Abdel-Wahab[SUP] 2 [/SUP], Hussam Askar[SUP] 2 [/SUP], Elsayed K Bakhiet[SUP] 1 [/SUP], Serageldeen Sultan[SUP] 8 [/SUP], Amgad A Ezzat[SUP] 9 [/SUP], Usama Abdel Raouf[SUP] 10 [/SUP], Magdy M Afifi[SUP] 1 [/SUP]
Affiliations
- PMID: 35563714
- DOI: 10.3390/cells11091408
Abstract
Human SARS-CoV-2 and avian infectious bronchitis virus (IBV) are highly contagious and deadly coronaviruses, causing devastating respiratory diseases in humans and chickens. The lack of effective therapeutics exacerbates the impact of outbreaks associated with SARS-CoV-2 and IBV infections. Thus, novel drugs or therapeutic agents are highly in demand for controlling viral transmission and disease progression. Mesenchymal stem cells (MSC) secreted factors (secretome) are safe and efficient alternatives to stem cells in MSC-based therapies. This study aimed to investigate the antiviral potentials of human Wharton's jelly MSC secretome (hWJ-MSC-S) against SARS-CoV-2 and IBV infections in vitro and in ovo. The half-maximal inhibitory concentrations (IC[SUB]50[/SUB]), cytotoxic concentration (CC[SUB]50[/SUB]), and selective index (SI) values of hWJ-MSC-S were determined using Vero-E6 cells. The virucidal, anti-adsorption, and anti-replication antiviral mechanisms of hWJ-MSC-S were evaluated. The hWJ-MSC-S significantly inhibited infection of SARS-CoV-2 and IBV, without affecting the viability of cells and embryos. Interestingly, hWJ-MSC-S reduced viral infection by >90%, in vitro. The IC[SUB]50[/SUB] and SI of hWJ-MSC secretome against SARS-CoV-2 were 166.6 and 235.29 µg/mL, respectively, while for IBV, IC[SUB]50[/SUB] and SI were 439.9 and 89.11 µg/mL, respectively. The virucidal and anti-replication antiviral effects of hWJ-MSC-S were very prominent compared to the anti-adsorption effect. In the in ovo model, hWJ-MSC-S reduced IBV titer by >99%. Liquid chromatography-tandem mass spectrometry (LC/MS-MS) analysis of hWJ-MSC-S revealed a significant enrichment of immunomodulatory and antiviral proteins. Collectively, our results not only uncovered the antiviral potency of hWJ-MSC-S against SARS-CoV-2 and IBV, but also described the mechanism by which hWJ-MSC-S inhibits viral infection. These findings indicate that hWJ-MSC-S could be utilized in future pre-clinical and clinical studies to develop effective therapeutic approaches against human COVID-19 and avian IB respiratory diseases.
Keywords: Wharton’s jelly stem cells; coronaviruses; infectious bronchitis virus (IBV); secretome; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).